Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 3, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 13, 2024
[ 12:00 AM ] - WOPRAI
Thu, January 4, 2024
[ 12:00 AM ] - WOPRAI
Fri, December 8, 2023
[ 12:00 AM ] - WOPRAI
Thu, August 10, 2023
[ 12:00 AM ] - WOPRAI
Tue, July 11, 2023
[ 12:00 AM ] - WOPRAI
Thu, July 7, 2022
[ 12:00 AM ] - WOPRAI
Thu, April 28, 2022
[ 12:00 AM ] - WOPRAI
Wed, February 23, 2022
[ 12:00 AM ] - WOPRAI
Wed, December 8, 2021
[ 12:00 AM ] - WOPRAI
Tue, October 26, 2021
[ 12:00 AM ] - WOPRAI
Wed, June 30, 2021
[ 12:00 AM ] - WOPRAI
Tue, January 12, 2021
Mon, January 6, 2020
[ 12:00 AM ] - WOPRAI
Wed, October 16, 2019
[ 12:00 AM ] - WOPRAI
Tue, June 5, 2018
Fri, May 12, 2017
Mon, November 28, 2016
Matt Hewitt Maintained (BLFS) at Strong Buy with Increased Target to $30 on, Aug 12th, 2024
Matt Hewitt of Craig-Hallum, Maintained "BioLife Solutions, Inc." (BLFS) at Strong Buy with Increased Target from $23 to $30 on, Aug 12th, 2024.
Matt has made no other calls on BLFS in the last 4 months.
There are 3 other peers that have a rating on BLFS. Out of the 3 peers that are also analyzing BLFS, 0 agree with Matt's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matt
- Carl Byrnes of "Northland Capital Markets" Maintained at Buy with Increased Target to $28 on, Friday, August 9th, 2024
- Steven Mah of "TD Cowen" Maintained at Strong Buy with Increased Target to $26 on, Wednesday, July 17th, 2024
- Robert Wasserman of "Benchmark" Upgraded from Hold to Strong Buy and Held Target at $25 on, Monday, May 13th, 2024
Contributing Sources